A “Game of Thrones” in Metastatic Renal Cell Carcinoma: Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors and Mammalian Target of Rapamycin Inhibitors Battling for Posi...

מאת Pal, Sumanta Kumar, Vogelzang, Nicholas J.
יצא לאור 2012

Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention

מאת Moyad, Mark A, Vogelzang, Nicholas J
הוצא לאור ב Asian J Androl (2015)

Malignant mesothelioma advances in pathogenesis, diagnosis, and translational therapies /

מאת Pass, Harvey I., Vogelzang, Nicholas J., Carbone, Michele.
יצא לאור 2005

New and Promising Strategies in the Management of Bladder Cancer

מאת Apolo, Andrea B., Vogelzang, Nicholas J., Theodorescu, Dan
הוצא לאור ב Am Soc Clin Oncol Educ Book (2015)

Effects of tumor burden reduction on survival in epithelioid malignant pleural mesothelioma

מאת Mansfield, Aaron S., Peikert, Tobias, Vogelzang, Nicholas J., Symanowski, James T.
הוצא לאור ב Mayo Clin Proc (2018)

Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer

מאת Halabi, Susan, Vogelzang, Nicholas J., Ou, San-San, Owzar, Kouros, Archer, Laura, Small, Eric J.
יצא לאור 2009

Novel therapies for metastatic renal cell carcinoma: Efforts to expand beyond the VEGF/mTOR signaling paradigm

מאת Pal, Sumanta Kumar, Williams, Stephen, Josephson, David Y., Carmichael, Courtney, Vogelzang, Nicholas J., Quinn, David I.
יצא לאור 2012

Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA

מאת Sartor, Oliver, Hoskin, Peter, Coleman, Robert E., Nilsson, Sten, Vogelzang, Nicholas J., Petrenciuc, Oana, Staudacher, Karin, Thuresson, Marcus, Parker, Christopher
הוצא לאור ב Prostate (2016)

CKD-EPI and Cockcroft-Gault Equations Identify Similar Candidates for Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

מאת Pal, Sumanta K., Ruel, Nora, Villegas, Sergio, Chang, Mark, DeWalt, Kara, Wilson, Timothy G., Vogelzang, Nicholas J., Yuh, Bertram E.
יצא לאור 2014

Sequential Therapy in Metastatic Renal Cell Carcinoma

מאת Hirsch, Bradford R., Burke, John M., Agrawal, Manish, Hauke, Ralph J., Hutson, Thomas E., Doshi, Gury, Fleming, Mark T., Vogelzang, Nicholas J.
הוצא לאור ב J Kidney Cancer VHL (2016)

Phase I Trial of Cediranib in combination with cisplatin and pemetrexed in chemo naive patients with unresectable malignant pleural mesothelioma (SWOG S0905)

מאת Tsao, Anne S., Moon, James, Wistuba, Ignacio I., Vogelzang, Nicholas J., Kalemkerian, Gregory P., Redman, Mary W., Gandara, David R., Kelly, Karen
הוצא לאור ב J Thorac Oncol (2017)

A PHASE II STUDY OF ESTRAMUSTINE, DOCETAXEL, AND BEVACIZUMAB IN MEN WITH CASTRATE RESISTANT PROSTATE CANCER: RESULTS OF CANCER AND LEUKEMIA GROUP B (CALGB) 90006

מאת Picus, Joel, Halabi, Susan, Kelly, W. Kevin, Vogelzang, Nicholas J., Whang, Young E., Kaplan, Ellen B., Stadler, Walter M., Small, Eric J.
יצא לאור 2010

TUMOR VOLUME CHANGES ON 1.5 TESLA ENDORECTAL MRI DURING NEOADJUVANT ANDROGEN SUPPRESSION THERAPY FOR HIGHER-RISK PROSTATE CANCER AND RECURRENCE IN MEN TREATED USING RADIATION THERA...

מאת D'Amico, Anthony V., Halabi, Susan, Tempany, Clare, Titelbaum, David, Philips, George K., Loffredo, Marian, McMahon, Elizabeth, Sanford, Ben, Vogelzang, Nicholas J., Small, Eric J.
יצא לאור 2007

Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis

מאת Vogelzang, Nicholas J., Pal, Sumanta K., Ghate, Sameer R., Swallow, Elyse, Li, Nanxin, Peeples, Miranda, Zichlin, Miriam L., Meiselbach, Mark K., Perez, Jose Ricardo, Agarwal, Neeraj
הוצא לאור ב Adv Ther (2017)

Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer

מאת Cheng, Heather H., Plets, Melissa, Li, Hongli, Higano, Celestia S., Tangen, Catherine M., Agarwal, Neeraj, Vogelzang, Nicholas J., Hussain, Maha, Thompson, Ian M., Tewari, Muneesh, Yu, Evan Y.
הוצא לאור ב Prostate (2017)

Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer

מאת Wong, Risa L., Duong, Mai T., Tangen, Catherine M., Agarwal, Neeraj, Cheng, Heather H., Vogelzang, Nicholas J., Hussain, Maha, Thompson, Ian M., Quinn, David I., Yu, Evan Y.
הוצא לאור ב Prostate Cancer Prostatic Dis (2020)

Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107

מאת Twardowski, Przemyslaw W., Tangen, Catherine M., Wu, Xiwei, Plets, Melissa R., Plimack, Elizabeth R., Agarwal, Neeraj, Vogelzang, Nicholas J., Wang, Jinhui, Tao, Shu, Thompson, Ian M., Lara, Primo
הוצא לאור ב Kidney Cancer (2017)

Cooperative group trials – Southwest Oncology Group (SWOG) innovations in advanced prostate cancer

מאת Dorff, Tanya B., Tangen, Cathy M., Crawford, E. David, Petrylak, Daniel P., Higano, Celestia S., Raghavan, Derek, Quinn, David I., Vogelzang, Nicholas J., Thompson, Ian M., Hussain, Maha H.A.
יצא לאור 2009

Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant chemotherapy

מאת Sonpavde, Guru, Goldman, Bryan H., Speights, V.O., Lerner, Seth P., Wood, David P., Vogelzang, Nicholas J., Trump, Donald L., Natale, Ronald B., Grossman, H. Barton, Crawford, E. David
יצא לאור 2009

Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma o...

מאת Smith, David C., Tangen, Cathy M., Hussain, Maha H.A., Van Veldhuizen, Peter J., Harrer, Grant W., Stuart, Robert K., Mills, Glenn M., Vogelzang, Nicholas J., Thompson, Ian M.
יצא לאור 2011